Nudge

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Nudge - overview

Established

2024

Location

San Francisco, CA, US

Primary Industry

Medical Devices & Equipment

About

Based in the US, Nudge provides a range of innovative non-invasive technologies designed to enhance cognitive engagement through neurofeedback and brain-computer interfaces for various use cases, including productivity and mental health improvement. Nudge is a technology firm specializing in whole-brain interfaces aimed at improving cognitive processes. Founded in 2024 and headquartered in San Francisco, US, the company recently pivoted to focus more on neurofeedback solutions. In August 2025, Nudge raised USD 100 mn in Series A funding co-led by Greenoaks Capital and Thrive Capital.


This funding round marks their total amount raised to USD 100 mn. The firm has completed 1 deal to date. Nudge specializes in whole-brain interfaces designed to enhance the way individuals engage with their cognitive processes. The company's primary offerings focus on innovative technologies that facilitate improved mental interaction through neurofeedback and brain-computer interfaces, addressing use cases such as enhancing productivity, improving mental health, and fostering more effective learning experiences.


Nudge's diverse customer base includes healthcare providers, educational institutions, and corporate entities looking to optimize employee performance and well-being, with a market reach extending to North America, Europe, and parts of Asia. Nudge generates revenue through direct-to-consumer sales and strategic partnerships with businesses and institutions. Clients access Nudge’s technologies through subscription-based models or one-time purchases, providing flexibility tailored to user needs. Pricing plans are centered around flagship products, including scalable comprehensive packages for organizations that encompass both hardware and software solutions, fostering lasting client relationships while expanding their footprint in the brain-interaction technology sector.


In August 2025, following their Series A funding of USD 100 mn, Nudge plans to utilize this investment to accelerate scalability and expand its product design and research teams. The company is focusing on developing new products aimed at enhancing cognitive engagement, with specific timelines for market entries yet to be disclosed. Additionally, Nudge is targeting expansion into international markets, particularly in Europe and Asia, to further broaden its global presence.


Current Investors

Greenoaks Capital, Thrive Capital

Primary Industry

Medical Devices & Equipment

Sub Industries

Biotechnology, Diagnostic Equipment, Therapeutic Devices, Medical Software

Website

www.nudge.com

Verticals

Artificial Intelligence, HealthTech

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.